Centene Corporation (CNC)
| Market Cap | 15.64B |
| Revenue (ttm) | 153.27B |
| Net Income (ttm) | 3.45B |
| Shares Out | 497.60M |
| EPS (ttm) | 6.72 |
| PE Ratio | 4.68 |
| Forward PE | 9.68 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 15,546,320 |
| Open | 32.25 |
| Previous Close | 32.52 |
| Day's Range | 31.40 - 32.50 |
| 52-Week Range | 31.40 - 80.59 |
| Beta | 0.44 |
| Analysts | Buy |
| Price Target | 64.75 (+105.95%) |
| Earnings Date | Jul 25, 2025 |
About CNC
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, and commercial organizations in the United States. The company operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healt... [Read more]
Financial Performance
In 2024, Centene's revenue was $147.17 billion, an increase of 4.09% compared to the previous year's $141.39 billion. Earnings were $3.31 billion, an increase of 22.32%.
Financial StatementsAnalyst Summary
According to 17 analysts, the average rating for CNC stock is "Buy." The 12-month stock price target is $64.75, which is an increase of 105.95% from the latest price.
News
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Centene
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Centene To Contact Him Directly To Discuss Their Options
Centene: Buy Signals Emerge After Capitulation-Like Sell-Off
Centene's stock plunged after withdrawing 2025 guidance due to higher medical costs, but the selloff appears to be a capitulation event. The stock is deeply oversold, trading at just 10x reduced 2025 ...
Centene Stock Down 40% — May Slide On $1 Trillion Medicaid Cuts
The Big Beautiful Bill Act cuts $1 trillion from Medicaid from which Centene gets 58% of its revenue. After plunging 40% will the stock drop more?
Centene's Punishment Overly Done - Contrarian Buy At A Deep Discount
CNC has been deeply punished for the suspended FY2025 adj EPS guidance, after supposedly reiterating the prior numbers in the FQ1'25 earnings call. It is apparent that the higher medical care activiti...
Centene Corporation (CNC) Investors See Over $11 Billion Of Shareholder Value Wiped Out In 1 Day Amid Independent Actuary Data, Withdrawn 2025 Guidance- Hagens Berman
SAN FRANCISCO , July 7, 2025 /PRNewswire/ -- On July 2, 2025, investors in Centene Corp. (NYSE: CNC) saw the price of their shares of this normally low-volatility stock crash 40%, after the company wi...
Molina Healthcare Trims Fiscal-Year Guidance Days After Centene Withdraws Its Outlook
The insurer says earnings pressure is expected to continue into the second half of the year.
Centene Corporation (CNC) Investors See Over $11 Billion Of Shareholder Value Wiped Out In 1 Day Amid Independent Actuary Data, Withdrawn 2025 Guidance – Hagens Berman
SAN FRANCISCO, July 03, 2025 (GLOBE NEWSWIRE) -- On July 2, 2025, investors in Centene Corp. (NYSE: CNC) saw the price of their shares of this normally low-volatility stock crash 40%, after the compan...
Centene's 40% Crash: Generational Buy Or Value Trap?
Centene's 40% drop after pulling 2025 guidance is driven by rising medical costs and margin pressure, but the sell-off appears overdone. Historical patterns show that similar sell-offs in 2016 and 202...
Centene's expected hit to EPS this year 'horrifying', says Jim Cramer
'Mad Money' host Jim Cramer dissects Centene's massive plummet following earnings.
Jim Cramer on what is behind Centene's 40% drop
'Mad Money' host Jim Cramer dissects Centene's massive plummet following earnings.
Jim Cramer gives his take on Centene's decline and the managed care sector
CNBC's Jim Cramer offered his take on Centene and the broader health insurance space as its stock plummeted when management unexpectedly withdrew full-year guidance. "Given this news from Centene, I t...
S&P 500 Gains and Losses Today: Centene Pulls Guidance, Health Insurance Stocks Fall
Major U.S. equities indexes finished Wednesday mixed as President Donald Trump announced that the U.S. has reached a trade deal with Vietnam.
Centene Faces Earnings Crunch as More Healthy Americans Exit Insurance Plans
The health-insurance provider is reckoning with multiple threats to its business, potentially leaving it with fewer and less-healthy enrollees signed up to its health-insurance plans.
Centene Tells United Healthcare To Hold Its Beer
Centene's stock plunged after slashing 2025 EPS guidance due to higher-than-expected morbidity and lower market growth in key states. The company's previous bullish guidance failed to materialize. De...
CNC Investors Have Opportunity to Join Centene Corporation Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)---- $CNC--CNC Investors Have Opportunity to Join Centene Corporation Fraud Investigation with the Schall Law Firm.
CNC Hits 8-Year Low, Big Banks Boost Dividends, STZ Earnings Rally
Centene (CNC) sold off more than 30% at the opening bell after withdrawing full-year guidance. Diane King Hall talks about how the "big, beautiful bill" plays a pivotal role in that downside price act...
Centene Corporation Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – CNC
LOS ANGELES--(BUSINESS WIRE)---- $CNC--Centene Corporation Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – CNC.
Centene's Medicaid business and healthcare costs are a problem, and its stock plunges
Centene's stock suffers a historic plunge as underestimation of healthcare costs leads the insurer to withdraw its full-year earnings outlook.
Centene: Is The 25% Fall In CNC Stock Justified?
Centene Corporation (NYSE:CNC) experienced a challenging Tuesday evening, witnessing a 25% drop in shares during after-hours trading on July 1st. The significant decline in the healthcare giant's stoc...
Centene, BrightView Holdings, ArriVent BioPharma And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining around 0.2% on Wednesday.
Centene plunges after pulling forecast on revenue pressure from Obamacare plans
Centene shares tumbled more than 25% in premarket trading on Wednesday after the health insurer withdrew its 2025 earnings forecast, citing a sharp decline in expected revenue from its marketplace pla...
Centene Stock Plummets 27%. What Sparked the Brutal Selloff.
It's been a tough year for health insurance stocks, with UnitedHealth also tumbling after the company pulled its guidance.
Centene Latest Insurer Facing Higher Costs As GOP Preps Bigger Hit
News government-subsidized health insurance provider Centene is withdrawing its 2025 financial guidance comes as the Republican-controlled Congress is poised to slash hundreds of billions of dollars i...
Facing Slower Growth, Health Insurer Centene Pulls 2025 Profit Outlook
Health insurer Centene, one of the nation's biggest providers of individual coverage under the Affordable Care Act known as Obamacare, on Tuesday withdrew its 2025 guidance, saying market growth in mo...
Centene withdraws 2025 forecast after review of marketplace risk adjustment
U.S. health insurer Centene said on Tuesday it has withdrawn its 2025 earnings forecast, sending its shares down nearly 22% in extended trading.